ReviewSurgery today2021
Robotic surgery for rectal cancer as a platform to build on: review of current evidence.
Review in Surgery today, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Mapping the evolving trends of robotic surgery in gastric and colorectal cancer: a clinical trial landscape analysis.Journal of robotic surgery · 2026Pooled it
- Key steps in exposure techniques for robotic total mesorectal excision (TME).Techniques in coloproctology · 2024Article
- Open vs. laparoscopic vs. robotic pouch excision: unveiling the best approach for optimal outcomes.Techniques in coloproctology · 2024Article
- A multi-docking strategy for robotic LAR and deep pelvic surgery with the Hugo RAS system: experience from a tertiary referral center.International journal of colorectal disease · 2024Article
- [Robotic rectal surgery].Chirurgie (Heidelberg, Germany) · 2024Review
- The death of laparoscopy.Surgical endoscopy · 2024Article
- Colorectal procedures with the novel Hugo™ RAS system: training process and case series report from a non-robotic surgical team.Surgical endoscopy · 2024Article
- Comparative study of robotic-assisted vs. laparoscopic surgery for colorectal cancer: a single-center experience.Frontiers in oncology · 2024Article
- Robotic complete mesocolic excision of right-sided colon cancer with bulky lymph node metastases using the da VinciOncology letters · 2022Article
- Robotic Surgery: A Narrative Review.Cureus · 2022Review
- Review
- The Role of Indocyanine Green Fluorescence in Rectal Cancer Robotic Surgery: A Narrative Review.Cancers · 2022Review
- Efficacy of a robotic stapler on symptomatic anastomotic leakage in robotic low anterior resection for rectal cancer.Surgery today · 2022Article
- MRI-detected extramural vascular invasion potentiates the risk for pathological metastasis to the lateral lymph nodes in rectal cancer.Surgery today · 2021Article
- [Evidence in minimally invasive oncological surgery of the colon and rectum].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2021Review
- Comparison of the perioperative outcomes of laparoscopic surgery, robotic surgery, open surgery, and transanal total mesorectal excision for rectal cancer: An overview of systematic reviews.Annals of gastroenterological surgery · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laparoscopy in colorectal surgery reduces the rate of postoperative complications, shortens the length of stay in hospital, and improves the quality of patient care. Despite these established benefits, the technical challenges of rectal resection for cancer have resulted in most operations being performed through open surgery in the USA. Moreover, controversy in the current literature questions the oncologic safety of a laparoscopic approach for rectal cancer. How then can surgeons innovate to overcome the technical challenges while preserving the critical oncological outcomes of high-quality rectal cancer surgery? Robotics may be a platform that allows us to overcome the technical challenges in the pelvis while maintaining both oncological outcomes and the benefits of a minimally invasive technique. Current evidence suggests that the quality of total mesorectal excision, the rates of circumferential margin involvement, and postoperative outcomes are comparable between robotic and laparoscopic surgery. While a robotic approach demonstrates lower conversion rates and reduced surgeon workload, the operative time is longer and initial costs are higher; however, time and future science will determine its true benefits. We review the current state of robotic surgery and its impact on rectal cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.